Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review

Naomi M Fuller,Christopher F McQuaid,Martin J Harker,Chathika K Weerasuriya,Timothy D McHugh,Gwenan M Knight,Naomi M. Fuller,Christopher F. McQuaid,Martin J. Harker,Chathika K. Weerasuriya,Timothy D. McHugh,Gwenan M. Knight

DOI: https://doi.org/10.1371/journal.ppat.1011574

IF: 7.464

2024-04-11

PLoS Pathogens

Abstract:Drug-resistant tuberculosis (DR-TB) threatens progress in the control of TB. Mathematical models are increasingly being used to guide public health decisions on managing both antimicrobial resistance (AMR) and TB. It is important to consider bacterial heterogeneity in models as it can have consequences for predictions of resistance prevalence, which may affect decision-making. We conducted a systematic review of published mathematical models to determine the modelling landscape and to explore methods for including bacterial heterogeneity. Our first objective was to identify and analyse the general characteristics of mathematical models of DR-mycobacteria, including M . tuberculosis . The second objective was to analyse methods of including bacterial heterogeneity in these models. We had different definitions of heterogeneity depending on the model level. For between-host models of mycobacterium, heterogeneity was defined as any model where bacteria of the same resistance level were further differentiated. For bacterial population models, heterogeneity was defined as having multiple distinct resistant populations. The search was conducted following PRISMA guidelines in five databases, with studies included if they were mechanistic or simulation models of DR-mycobacteria. We identified 195 studies modelling DR-mycobacteria, with most being dynamic transmission models of non-treatment intervention impact in M . tuberculosis (n = 58). Studies were set in a limited number of specific countries, and 44% of models (n = 85) included only a single level of "multidrug-resistance (MDR)". Only 23 models (8 between-host) included any bacterial heterogeneity. Most of these also captured multiple antibiotic-resistant classes (n = 17), but six models included heterogeneity in bacterial populations resistant to a single antibiotic. Heterogeneity was usually represented by different fitness values for bacteria resistant to the same antibiotic (61%, n = 14). A large and growing body of mathematical models of DR-mycobacterium is being used to explore intervention impact to support policy as well as theoretical explorations of resistance dynamics. However, the majority lack bacterial heterogeneity, suggesting that important evolutionary effects may be missed. The emergence of drug-resistant tuberculosis (DR-TB), where the causative bacterium Mycobacterium tuberculosis is resistant to key antibiotics such as rifampicin and isoniazid, poses a significant threat to TB control efforts. To gain a broader understanding of the challenges surrounding DR-TB, mathematical models are increasingly being employed to estimate the impact of interventions, effectiveness of treatment, and to predict the evolution of drug-resistance. However, pragmaticism surrounding model construction often means that important aspects, such as bacterial heterogeneity, are overlooked. We undertook a systematic review of the existing DR-mycobacterium modelling literature, with the specific aim of capturing methods for including bacterial heterogeneity. Our analysis revealed that most models of drug-resistance in mycobacteria primarily focus on intervention strategies and cost-effectiveness analyses, with minimal attention to bacterial heterogeneity. Where heterogeneity is included it mostly consisted of different fitness costs for resistance.

microbiology,virology,parasitology